Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) HEDIS® Measure(APM-E)
As a reminder, when prescribing antipsychotic medications in children and adolescents 1-17 years of age, it is a requirement to assess a child’s risk for developing serious metabolic health complications associated with poor cardiometabolic outcomes in adulthood.
MC follows all AHCCCS guidance regarding the provider’s responsibility to bill NDC as follows: The billing requirements for drugs administered in outpatient clinical settings are in accordance with and support of the Federal Deficit Reduction Act of 2005, which mandates that all providers submit the National Drug Code (NDC) on all claims with procedure codes for physician-administered drugs in outpatient clinical settings. These services are currently represented on submitted claims using the Healthcare Common Procedure Coding System (HCPCS) codes.
